Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: A comparison with bone marrow findings

Clinical and Laboratory Haematology

Volumn 24, Issue 6, 2002, Pages 361-367

  Akel, Salem ^a,b   Kolialexi, A ^a   Mavrou, A ^a   Metaxotou, C ^a   Loukopoulos, D ^a   Yataganas, X ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b CCR   (United States)

Author keywords

BCR ABL; Chronic myeloid leukemia; Fluorescence in situ hybridization; Immunophenotyping; T lymphocytes

Indexed keywords

BCR ABL PROTEIN; CD3 ANTIGEN; GAMMA INTERFERON; HYDROXYUREA; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ARTICLE; BLOOD SMEAR; BONE MARROW EXAMINATION; CANCER DIAGNOSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; INTERPHASE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; T LYMPHOCYTE SUBPOPULATION; BLOOD; BONE MARROW; COMPARATIVE STUDY; LYMPHOCYTE COUNT; MINIMAL RESIDUAL DISEASE; MYELOID LEUKEMIA; PATHOLOGY; REMISSION;

ANTIGENS, CD3; ANTINEOPLASTIC AGENTS; BONE MARROW; FUSION PROTEINS, BCR-ABL; HUMANS; HYDROXYUREA; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; INTERPHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LYMPHOCYTE COUNT; NEOPLASM, RESIDUAL; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0036885719     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.00470.x     Document Type: Article

References (21)

1. Akel S., Kolialexi A., Mavrou A., Metaxotou C., Loukopoulos D. & Yataganas X. (2000) Evaluation at single level of residual Philadelphia negative Ph(-) hemopoietic stem cells (HSC) in chronic phase CML patients. Cancer Genetics and Cytogenetics 122, 93-100.
2. Altman D.G. (1991) Some common problems in medical research. Practical statistics for medical research, 1st edn. pp. 397-439. Chapman and Hall, New York.
3. Arnoldus E.P.J., Wiegant J., Noordermer I.A., Wessels J.W., Beverstock G.C. & Grosveld G.C. (1990) Detection of the Philadelphia chromosome in interphase nuclei. Cytogenetics and Cell Genetics 54, 108-111.
4. Bartram C.R., Raghavachar A., Anger B., Stain C. & Bettelheim P. (1987) T-lymphocytes lack rearrangement of the BCR gene in Philadelphia chromosome chronic myelocytic leukemia. Blood 69, 1682-1685.
5. Bentz M., Cabot G., Moos M., Speicher M.R., Ganser A., Lichter P. & Dohner H. (1996) Detection of chimeric BCR/ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83, 1992-1996.
6. Buckton K.E, Brown W.M. & Smith P.G. (1967) Lymphocytes survival in men treated with X ray for ankylosing Spondylitis. Nature 214, 470-473.
7. Buno I., William A.W., Zinsmeister A.R., Dietz-Band J., Silver R.T. & Dewald G.W. (1998) A special fluorescence in situ hybridization to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood 92, 2315-2321.
8. Caricochea B., Chase A., Lazavidou A. & Goldman J.M. (1994) T lymphocytes in chronic myelogenous leukemia (CML): no evidence of BCR/ABL fusion gene detected by flourescence in situ hybridization in 14 patients. Leukemia 8, 1197-1201.
9. Chen Z., Notohamiprodjo M., Paul D.R., Lane F.B., Morgan R., Stone J.F. & Sandberg A.A. (1997) Some observations on fluorescence in situ hybridization: evaluation of chronic meylocytic leukemia. Cancer Genetics and Cytogenetics 98, 1-3.
10. Cross NC. (1997) Assessing residual leukemia. Baillier's Clinical Haematology 10, 389-403.
11. Dewald G.W., Juneau A.L., Schad C.R. & Tefferi A. (1997) Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia. Cancer Genetics and Cytogenetics 94, 59-66.
12. Dewald G.W., Wayatt W.A., Juneau A.L., Carlson R.O., Zinsmeister A.R., Jalal S.M., Spurbeck J.L. & Silver R.T. (1998) Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 91, 3357-3336.
13. Haferlach T., Winkemann M., Nickenig C., Meeder M., Ramm-Petersen L.R., Schoch R.., Nickelsen M., Weber-Matthiesen K., Schlegelberger B., Schoch C., Gassmann W. & Loffler H. (1997) Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukemia? An answer at single cell level by combining May-Grunwald-Giemza staining and fluorescence in situ hybridization techniques. British Journal of Haematology 97, 99-106.
14. Hughes T.P., Morgan G.J., Martiat P. & Goldman J.M. (1991) Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 77, 874-878.
15. Le Gousil S., Talmant P., Milpied N., Daviet A., Ancelot M., Moreau P., Harousseau J.L., Bataille R. & Anvet-Loiseau H. (2000) Fluorescence in situ hybridization on peripheral-blood specimens is reliable method to evaluate cytogenetic response in chronic myeloid leukemia. Journal of Clinical Oncology 18, 1533-1538.
16. Mavrou A., Kolialexi A., Zehng Y.L., Metaxotou C. & Biannchi D.W. (1999) Improved specificity of NRBC detection in chorionic villus sample supernatant fluids using anti-Zeta and anti-Epsilon monoclonal antibodies. Fetal Diagnosis Therapy 14, 291-295.
17. Muhlman J., Thaler J., Hilbe W., Bechter O., Erdel M., Utermann G. & Duba HC. (1998) Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring of Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment. Genes, Chromosomes and Cancer 21, 90-100.
18. Raskind W.H. & Fialkow P.J. (1987) The use of cell markers in the study of human hemopoietic neoplasia. Advances in Cancer Research 49, 127-132.
19. Takahashi N., Miura I., Siatoh K. & Miura A.B. (1998) Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 92, 4758-4763.
20. Talpaz M., Kantarjian H., Mc Credie K., Trujillo J., Keating M. & Gutterman J.U. (1986) Hematological remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. New England Journal of Medicine 314, 1065-1069.
21. Tsukamoto N., Karasawa M., Maehara T., Okamoto K., Sakai H., Naurse T., Morita K., Tsuchiya J. & Omine M. (1996) The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogeneous leukemia. Annals of Hematology 72, 61-65.